DMK Pharmaceuticals (DMK) - 2022 Q4 - Earnings Call Transcript
DMK Pharmaceuticals DMK Pharmaceuticals (US:DMK)2023-03-17 20:50
Financials

Robert Uhl - MD, ICR Westwicke Operator Our format for this call will consist of prepared remarks from Adamis Management and Dr. Versi, followed by a Q&A session. This call is being webcast and will be available for replay in the Investors section of our website at adamispharmaceuticals.com. David Marguglio Adamis Pharmaceuticals Corporation (ADMP) Q4 2022 Results Conference Call March 16, 2023 5:00 PM ET Dr. Eboo Versi - CEO, DMK Pharmaceuticals Robert Uhl Further, nothing in todayÂ's presentation should b ...